SYSTEM AND METHOD FOR TITRATING BASAL INSULIN DOSES

    公开(公告)号:US20240058532A1

    公开(公告)日:2024-02-22

    申请号:US18383133

    申请日:2023-10-24

    Applicant: Dexcom, Inc.

    CPC classification number: A61M5/1723 A61M5/16877

    Abstract: A continuous glucose monitor (CGM)-driven basal insulin titration system and method for patients with Type 2 Diabetes can be adapted to the needs and concerns of subjects just starting on basal insulin therapy. The method uses as inputs historical CGM data, basal insulin dose information, reports of hypoglycemia, and past recommendations and generates an adjusted insulin dose along with a report advising whether to continue the titration process, or to stop. The method can generate a new recommendation on a regular basis (e.g., each day) until it determines an adequate, consistent dose size.

Patent Agency Ranking